Replies to post #6244 on Arch Therapeutics Inc (ARTH)

[21money21]

I believe the doubt has already been created here with the delays and lack of info being relayed and explained, hence the price decline. I believe the push for 510k mid year was in reaction to the ce delay and trying to get something going. Originally was supposed to be for internal and external by year end. Ce has delayed internal testing and therefore can only apply for external any time soon anyway. Just hope they stick to mid year timeline to restore a little faith in norchi. Gl longs next couple months are key here in my mind